Search
for
Sort by
Research 181–210 of 1000+
- Complex Regional Pain Syndrome Type I : measurements and treatment
- 13. Wound Healing & Hair
- 4. Bullous/Mucous Membrane
- Cutaneous manifestations of systemic infection in children
- Anthelminthic drugs
- Cutaneous complications of chemotherapeutic agents
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Adipose-derived cellular and cell-derived regenerative therapies in dermatology and aesthetic rejuvenation
- Microneedle-Based Approaches for Skin Disease Treatment
- Parkinson's disease and skin
- Complications in Hair Restoration Surgery
- Lupus erythematosus: considerations about clinical, cutaneous and therapeutic aspects
- Herbal Treatment for Dermatologic Disorders
- Biological Profile of Cortexolone 17a-Propionate (CB-03-01), a New Topical and Peripherally Selective Androgen Antagonist
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Liposome-based drug delivery systems for skin wound healing: a promising drug delivery strategy
- Hair Cortisol: A Biomarker of Chronic Stress in Animals and its Association with Reproduction
- Subject Index
- Low Level Laser and Light Therapy
- Therapies
- Impact of Chemotherapeutic Drug on People living with Cancer
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Experiences with Parieto-Occipital Flaps in Hair Transplantation
- Poster session
- Tissue engineering of human hair follicles using a biomimetic developmental approach
- Promoting of Biomechanics’ Properties Incisional Wound Repair by Mesenchymal Stem Cell Transplantation
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Farmácia Militar do Laboratório Nacional do Medicamento, Porto e Serviços Farmacêuticos do Centro Hospitalar Universitário do Porto (Hospital de Santo António), EPE, Porto
- Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto
- Intensive immunosuppression in patients with disseminated sclerosis. I. Clinical response.